IGF1 and amyotrophic lateral sclerosis: Importantly, at this stage we cannot determine if liver and IGF-1 related pathology contributes causally to the development of ALS symptoms, or if it is merely an epi-phenomenon reflecting systemic aberrations resulting from the ubiquitous expression of mSOD1 protein in this mouse model.